Depressive Symptoms in a General Population: Associations with Obesity, Inflammation, and Blood Pressure
Table 2
Logistic regression analysis for the association of certain parameters with depressive disorder, by gender.
Total
Men
Women
OR 95% CI
OR 95% CI
OR 95% CI
Model 1
241/1919†
57/963†
184/956†
Female gender
3.97
2.87; 5.49
Age, 11 years
0.91
0.77; 1.06
1.07
0.82; 1.41
0.85
0.70; 1.02
Body mass index, 5 kg/m2
1.08
0.94; 1.23
0.97
0.69; 1.35
1.10
0.96; 1.28
Systolic b. pressure, 20 mmHg
0.74
0.63; 0.87
0.80
0.58; 1.10
0.72
0.60; 0.89
Model 2
189/1594†
49/822†
140/772†
Female gender
3.48
2.20; 5.52
Age, 11 years
0.90
0.76; 1.07
1.04
0.77; 1.44
0.84
0.68; 1.03
Body mass index, 5 kg/m2
1.01
0.87; 1.18
0.99
0.85; 1.43
1.03
0.87; 1.22
Systolic b. pressure, 20 mmHg
0.74
0.62; 0.89
0.75
0.52; 1.06
0.74
0.60; 0.92
Fasting glucose, 40 mg/dL
1.13
1.00; 1.32
1.27
1.00; 1.55
1.08
0.89; 1.27
Current versus never smoking
0.83
0.45; 1.53
0.92
0.42; 2.00
0.99
0.30; 3.28
Antihypert. drug use, yes/no
1.19
0.83; 1.73
1.20
0.73; 1.81
1.17
0.76; 1.79
Lipid-lower. drug use, yes/no
1.08
0.63; 1.88
1.07
0.54; 2.08
1.03
0.54; 1.97
†number of depressive disorder/total number. 201/61 antihypertensive/lipid-lowering drug usage in men, 322/75 usage in women, respectively. Significant values are highlighted in boldface.
